SCHEMBL6196680

SCHEMBL6196680

C[C@@H]1CNc2c(cccc2[N+](=O)[O-])C(=O)N1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.41
S100A4 P26447 2/20 0.41
KMT2A Q03164 2/20 0.40
MAPT P10636 1/20 0.40
RECQL P46063 1/20 0.40
MCL1 Q07820 1/20 0.40
RXFP1 Q9HBX9 1/20 0.40
PTPRC P08575 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
SMN1; SMN2 Q16637 3/20 0.36
NPC1 O15118 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP2C19 P33261 1/20 0.36
RAB9A P51151 1/20 0.36
CDK1 P06493 4/20 0.36
MAPKAPK2 P49137 4/20 0.36
MEN1 O00255 1/20 0.36
PKM P14618 1/20 0.36
CHRNB2 P17787 1/20 0.36
CHRNA4 P43681 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6200104 1.00 TSHR (0.41) TSHRS100A4KMT2AMAPTRECQL
SCHEMBL6196688 1.00 TSHR (0.41) TSHRS100A4KMT2AMAPTRECQL
SCHEMBL31297473 0.89 S100A4 (0.41) TSHRS100A4KMT2AMAPTRECQL
SCHEMBL7908204 0.80 S100A4 (0.45) TSHRS100A4KMT2AMAPTRECQL
SCHEMBL7896197 0.80 S100A4 (0.45) TSHRS100A4KMT2AMAPTRECQL
SCHEMBL7908209 0.80 S100A4 (0.45) TSHRS100A4KMT2AMAPTRECQL
SCHEMBL7896203 0.80 S100A4 (0.45) TSHRS100A4KMT2AMAPTRECQL
SCHEMBL7896207 0.80 S100A4 (0.45) TSHRS100A4KMT2AMAPTRECQL
SCHEMBL2061190 0.78 S100A4 (0.41) TSHRS100A4KMT2AMAPTRECQL
SCHEMBL6200350 0.77 TSHR (0.45) TSHRSMN1; SMN2NPC1CYP1A2CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1208104-B1 TRICYCLIC INHIBITORS OF POLY(ADP-RIBOSE) POLYMERASES AGOURON PHARMA (US) 2005-01-19 EP disclosed
US-6548494-B1 3,4-dihydro-2H-(1,4)diazepino(6,7,1-hi)indol-1-one or 1-thione derivatives where indole C3 could also be N; use treating cancers as well as stroke, head trauma, and neurodegenerative diseases AGOURON PHARMACEUTICALS, INC. 2003-04-15 US disclosed
EP-1208104-A2 TRICYCLIC INHIBITORS OF POLY(ADP-RIBOSE) POLYMERASES AGOURON PHARMACEUTICALS, INC. (US) 2002-05-29 EP disclosed
WO-2001016136-A2 TRICYCLIC INHIBITORS OF POLY(ADP-RIBOSE) POLYMERASES AGOURON PHARMACEUTICALS, INC. (US) 2001-03-08 WO disclosed